Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia

NCT00756002 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

259

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

DRUG: Ramelteon
DRUG: Placebo

Sponsor

Takeda